July 23, 2019

Q2SM Oncology Infographic

Providing one global lab partner to support your oncology research from discovery to post-market
According to the World Health Organization, annual cancer cases will rise from 14 million in 2012 to 22 million within the next 2 decades. Q2 Solutions is an oncology development partner that understands the complexity of cancer – including the underlying biologic processes and clinically relevant lab technologies required for delivering valuable insights to shape better outcomes. Q2 industry-leading expertise and innovative end-to-end lab services offer comprehensive oncology drug development solutions from discovery to post-market

View our infographic to learn more about Q2 Oncology expertise for your clinical development needs.

Related Services:
Q2 Solutions Central Laboratory Services

Optimized logistics, deeper science, better insights

The Power of the Central Laboratory for Immuno-Oncology Drug Development

Planning and implementing biomarker testing for immuno-oncology trials

Exploring the challenges with the diverse clinical biomarker requirements

Read More